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analysis of Toll-like receptors in primary 
healthy human nasal epithelial cells shows no 
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Abstract 
Background: Innate immune recognition via Toll-like receptors (TLRs) on barrier cells like epithelial cells has been 
shown to influence the regulation of local immune responses. Here we determine expression level variations and 
functionality of TLRs in nasal epithelial cells from healthy donors.
Methods: Expression levels of the different TLRs on primary nasal epithelial cells from healthy donors derived from 
inferior turbinates was determined by RT-PCR. Functionality of the TLRs was determined by stimulation with the 
respective ligand and evaluation of released mediators by Luminex ELISA.
Results: Primary nasal epithelial cells express different levels of TLR1-6 and TLR9. We were unable to detect mRNA of 
TLR7, TLR8 and TLR10. Stimulation with Poly(I:C) resulted in a significant increased secretion of IL-4, IL-6, RANTES, IP-10, 
MIP-1β, VEGF, FGF, IL-1RA, IL-2R and G-CSF. Stimulation with PGN only resulted in significant increased production of 
IL-6, VEGF and IL-1RA. Although the expression of TLR4 and co-stimulatory molecules could be confirmed, primary 
nasal epithelial cells appeared to be unresponsive to stimulation with LPS. Furthermore, we observed huge individual 
differences in TLR agonist-induced mediator release, which did not correlate with the respective expression of TLRs.
Conclusion: Our data suggest that nasal epithelium seems to have developed a delicate system of discrimina-
tion and recognition of microbial patterns. Hypo-responsiveness to LPS could provide a mechanism to dampen the 
inflammatory response in the nasal mucosa in order to avoid a chronic inflammatory response. Individual, differential 
expression of TLRs on epithelial cells and functionality in terms of released mediators might be a crucial factor in 
explaining why some people develop allergies to common inhaled antigens, and others do not.
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Background
The mucosal barrier of the nose forms the first line of 
defence against air pollutants, airborne allergens, and 
(non-) pathogenic microorganisms. Epithelial cells are 
the outer lining of the mucosa of the nasal airway and 
play, besides their role as passive physical barrier, an 
important role in orchestrating innate and adaptive 
immune responses [1–3]. Epithelium can trigger anti-
microbial responses by recognizing pathogen-associated 
molecular patterns (PAMPs) through the sentinel action 
of pattern recognition receptors (PRRs) like Toll-like 
receptors (TLRs).
Toll-like receptors are evolutionarily conserved pat-
tern recognition receptors of the innate immune system 
[4]. Until now, 13 mammalian TLRs have been charac-
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and TLR13, specific ligands have been identified [5, 6]. 
The first group of receptors recognize bacterial products. 
TLR2 is activated by a variety of bacterial lipoproteins, 
peptidoglycans (PGN), and lipoteichoic acids (LTA), by 
forming a heterodimer with TLR1 or TLR6 [7, 8]. TLR4 
appears to form homodimers and under participation of 
adaptor molecules like MD-2 and CD14 this TLR recog-
nizes lipopolysaccharide (LPS) from the outer membrane 
of gram-negative bacteria. Originally thought to be a 
receptor only for LPS, TLR4 now emerges as a molecule 
responsible for signalling induced by a broad variety of 
molecules such as respiratory syncytial virus protein 
F [9], fungal components [10], or endogenous ligands 
like heat shock proteins, lung surfactant protein A, and 
beta-defensin [11–13]. Lastly, TLR5 recognizes bacterial 
Flagellin. Viral compounds trigger endosome-associated 
receptors, such as TLR3 by double-stranded (ds) RNA 
or its synthetic analogon polyinosinic polycytidylic acid 
(Poly I:C) and viral single stranded (ss) RNA signals via 
TLR7 and TLR8. DNA-containing CpG motifs are recog-
nized via TLR9 [14, 15].
Although TLRs can be involved in the initiation of 
adaptive immune responses through their presence on 
dendritic cells (DCs), they may also indirectly affect the 
adaptive immune response. Innate immune recognition 
via TLRs on barrier cells like epithelial cells has been 
shown to determine the functional properties of tissue-
resident DCs, thereby instructing the outcome of anti-
gen-specific immunity [16]. The overall complexity of the 
contribution of TLRs on immune responses can be influ-
enced by several factors like their relative abundance, 
their individual expression pattern, or the timing of expo-
sure. For example, stimulation of TLR2 and TLR4 signal-
ling pathways has been shown to both drive [16, 17] and 
inhibit [18, 19] the development of Th2-mediated allergic 
inflammation in different experimental mouse models. 
Moreover, the impact of TLR4 stimulation on allergic 
inflammation is highly dependent upon the dose of the 
TLR4 agonist, with high LPS concentrations inducing 
Th1-responses and low concentrations inducing Th2-
polarized inflammatory responses [20].
The LPS-induced pulmonary burden varies between 
different respiratory compartments and might therefore 
explain the functional differences between bronchial and 
alveolar epithelial cells with respect to LPS-dependent 
cytokine release. It is widely believed that alveolar epi-
thelial cells are unresponsive to LPS due to low or absent 
expression of TLR4 and/or CD14 or MD-2 [21]. In con-
trast to this it has been reported that lung epithelial cells 
do express TLR 1–6, including adaptor molecules like 
CD14 and MD-2, with bronchial epithelial cells showing 
CD14-dependent activation of TLR4 and alveolar epithe-
lial cells showing LPS-binding protein (LBP)-dependent 
inhibition of TLR4 signalling [22, 23], confirming the rel-
evance of co-factors for a proper TLR signalling. Small 
airway epithelial cells have been shown to express mRNA 
for the TLRs 1–6 and can respond to various stimuli such 
as viruses or bacteria resulting in the release of different 
pro- and anti-inflammatory cytokines and chemokines 
[24–26].
At present only limited data is available on the expres-
sion of TLRs by nasal epithelial cells. Claeys et al. showed 
constant expression of TLR2 and TLR4 in tissue biopsies 
from patients with nasal polyposis or chronic rhinosinus-
itis and in healthy individuals [27]. Isolated nasal epithe-
lial cells from nasal polyps were shown to constitutively 
express mRNA of all 10 TLRs, with more pronounced 
expression of TLR 1–6 [28]. Primary nasal polyp epithe-
lial cells express functional TLR3 and TLR4 and release 
high concentrations of proinflammatory chemokines 
and cytokines upon stimulation with dsRNA [29]. Until 
only one study investigated the expression and function 
of some but not all TLRs on primary nasal epithelial 
cells from non-allergic, non-diseased individuals specifi-
cally [30]. Given the role of TLRs expressed on epithe-
lial cells within the induction of immune responses, the 
relatively limited knowledge on the expression of TLRs 
in nasal epithelium, and the protective effect of TLR 
polymorphism in childhood asthma [31], the aim of this 
study was to determine the expression and functionality 




Nasal tissue was obtained from 10 non-allergic ENT 
patients (defined by negative skin prick test or radioal-
lergosorbent test (RAST)) with septum deviations that 
required inferior turbinectomy. Patients were between 18 
and 65 years of age, were nonsmokers, had not received 
topical corticosteroids for at least 4 weeks before surgery, 
and were free of any respiratory tract infections. The 
study was reviewed and approved by the medical ethical 
committee of the Academic Medical Center Amsterdam 
and all patients gave their informed consent.
Epithelial cell culture
Primary nasal epithelial cells were obtained by digest-
ing nasal turbinates of non-allergic patients with 0.5 mg/
ml collagenase 4 (Worthington Biochemical Corp., 
Lakewood, NJ) for 1  h in Hanks’ balanced salt solution 
(HBSS; Sigma-Aldrich, Zwijndrecht, The Netherlands). 
Subsequently, epithelial cells were isolated by magnetic 
activated cell sorting (MACS), according to the manu-
facturers instruction (Miltenyi Biotec, Leiden, The Neth-
erlands), resuspended in bronchial epithelial growth 
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medium (BEGM) (Lonza Clonetics, Breda, The Neth-
erlands), and seeded in a 75  ml flask. Culture medium 
was replaced every other day. Cells were grown to 80 % 
confluency in fully humidified air containing 5 % CO2 at 
37 °C.
NCI-H292 human airway epithelial cells (American 
Type Culture Collection, Mannassas, VA, USA) were 
cultured in RPMI 1640 medium (Invitrogen, Breda, The 
Netherland) supplemented with 1.25  mM  l-glutamine, 
100  U/ml penicillin, 100  μg/ml streptomycin and 10  % 
(v/v) fetal bovine serum (HyClone, Logan, UT, USA). 
Cells were grown in fully humidified air with 5 % CO2 at 
37 °C and sub cultured weekly.
TLR stimulation experiment
Cells were cultured up to a confluence of 80  % in a six 
wells plate and incubated for 24 h in IMDM without sup-
plements. Culture medium was removed and cells were 
stimulated with different TLR-agonists diluted in IMDM 
or with IMDM alone (control condition) for 24 h. Super-
natants were removed after 1, 4, and 24 h and stored for 
further analysis; cells were used for RNA extraction. Each 
experiment was performed in triplicate. LPS (Escheri-
chia coli), PGN (Staphylococcus aureus), and dsRNA 
(poly(deoxyinosinic-deoxycytidylic acid)) were from 
Sigma-Aldrich. ssRNA (LyoVec) and flagellin (Salmo-
nella typhimurium) were from InvivoGen and the ligands 
were used at optimal concentrations as determined in a 
previous dose range finding experiment: PGN: 10  μg/
mL, Poly(I:C): 20  μg/mL, LPS 1  μg/mL, Flagellin: 1  μg/
mL, and CpG2216: 0.5 μM. As positive controls we used 
TNF-α (25 ng/mL) and IL-1β (10 ng/mL).
RNA extraction and Real‑time quantitative RT‑PCR analysis
PCR was used to validate the differential expression of 
selected genes. Isolated mRNA (Kit from Macherey–
Nagel, Düren, Germany) was transcribed into cDNA 
using the MBI Fermentas first strand cDNA kit. cDNA 
transcripts were quantified by real-time quantitative 
PCR (iCycler iQ MultiColor Real-Time PCR Detection 
System; Bio-Rad) with specific primers [32] and general 
SYBR green (Bio-Rad) fluorescence detection. mRNA 
expression of each sample was normalized to GAPDH. 
All PCRs have been performed for all participants on 3 
biological replicates. Expression changes are presented as 
2−ΔCt indicating the difference in threshold cycle between 
the housekeeping gene GAPDH and the investigated TLR 
gene.
FACS analysis
For flow cytometry analysis cells were stained with 
CD14-PE-Cy7 (1:20, BD Bioscience, Breda, the Nether-
land), TLR4-APC (1:10, ebioscience, San Diego, USA) or 
left untreated. Cell numbers were quantified using the 
BD FACS Cantoll flowcytometer, histograms were gen-
erated using flowjo software version 7.6.2 (Treestar Inc, 
Ashland-OR, USA.
Determining cytokine and chemokine production by ELISA
Cell free supernatants of stimulated and control treated 
cells were stored at −20 °C until analysis. Cytokine levels 
in supernatant of cells were determined by ELISA (IL-6 
and IL8, BioSource International Camarillo-CA, USA) or 
using the xMAP technology (Luminex Corporation, Aus-
tin-TX, USA). A Bio-Plex Human Cytokine 17-Plex Panel 
kit (Bio-Rad, Veenendaal, The Netherlands). Concentra-
tions were calculated from a dilution series of standards 
using the Luminex software. Lower detection limits are 
indicated per cytokine.
Statistical analysis
Assessment of statistical significance for Luminex data 
was performed using two-tailed Student’s t tests with 
GraphPad Prism. P values <0.05 were considered signifi-
cant. Relationships between parameters were assessed 
using Pearson’s correlation analysis.
Results
Baseline expression and functionality of TLR in human 
nasal epithelial cells
As shown in Figs. 1 and 2, primary nasal epithelial cells 
from healthy donors express TLR1 to TLR6 and TLR9, 
but not TLR7 and TLR8, and TLR10. Interestingly, we 
observed a huge individual variability spanning several 
10 log-fold differences in the baseline expression of the 
TLRs to the extent that some healthy individuals do not 
express TLRs that are expressed by others.
In order to determine the functionality of the detected 
TLRs we stimulated primary nasal epithelial cells with 
their purified specific TLR ligands and used TNF-α and 
IL-1β as positive control to show the ability of our epi-
thelial cells to respond to external triggers. As shown 
in Fig.  3, stimulation of primary heathy epithelial cells 
by PGN, Poly(I:C), and Flagellin resulted in increased 
release of IL-6 and IL-8 confirming the biological func-
tionality of TLR2, TLR3, and TLR5 respectively. Remark-
ably, healthy primary nasal epithelial cells do not seem to 
respond to TLR4 ligation by LPS (Fig. 3) despite express-
ing the TLR4 gene and the use of a biological active LPS, 
as seen by the positive response in the epithelial cell line 
H292 (Fig.  4). Furthermore, we could show (Figs.  5, 6) 
surface expression of TLR4 and CD14, and co-expression 
of the adaptor MD-2 that are indispensable for proper 
TLR4 signalling [33, 34].
In a next step we analyzed, which additional cytokines 
and chemokines are released from primary nasal epithelial 
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cells in response to activation by different TLR ligands. 
As shown in Table  1 the multiplex ELISA showed that 
stimulation of primary nasal epithelial cells with Poly(I:C) 
resulted in a significant increased secretion of IL-4, IL-6, 
RANTES, IP-10, MIP-1β, VEGF, FGF, IL-1RA, IL-2R, and 
G-CSF. Furthermore, stimulation with PGN resulted in 
significantly increased production of IL-6, IL-1RA, and 
VEGF. In contrast to stimulation of epithelial TLR2 and 
TLR3, and confirming our previous observations, stimu-
lation with a high concentration of LPS did not result in 
increased secretion of any cytokines or chemokines.
No correlation between TLR expression levels and level 
of cytokine release
Strikingly, our data also revealed large individual differ-
ences in cytokine expression patterns. To investigate 
the functional consequences of this variation we first 
determined the individual mediator levels of all donors 
after stimulation with Poly(I:C). As shown in Fig. 7, some 
individuals seemed to be high responders (individual 3 
and 9), while nasal epithelial cells from others (e.g. indi-
vidual 11) hardly produced any significant levels of the 
mediators included in the assay used. Furthermore, these 
induction levels were not related to the expression levels 
of TLR3 (data not shown).
Discussion
Epithelial cells are uniquely positioned at the interface 
between inside and outside of the organism, which makes 
them perfect candidates for initiating and orchestrat-
ing local immune responses. In addition to establish-
ing which TLR receptors are expressed in primary nasal 
epithelial cells from healthy individuals, our data fur-
thermore suggest that nasal epithelium has developed a 
delicate response system towards microbial exposures. 
Firstly, despite the presence of TLR4 and its prime co-
stimulatory molecules CD14 and MD-2, nasal epithelium 
from healthy individuals does not respond to LPS. As the 
nasal mucosa is constantly exposed to high concentra-
tions of endotoxin, this unresponsiveness could provide 
a mechanism to dampen the inflammatory response in 
the nasal mucosa in order to avoid a chronic inflam-
matory response. Secondly, levels of TLR expression in 
individuals varies strongly, to the extent that some indi-
viduals not express TLRs that others do. Thirdly, not only 
are the expression levels different between individuals, 
Fig. 1 Toll-like Receptor (TLR) mRNA expression by primary nasal epithelial cells from 10 healthy patients undergoing turbinectomy (n = 10). TLR 
1-10 mRNA expression was analyzed by quantitative RT-PCR. Results were normalized using GAPDH as endogenous control. Expression changes are 
presented as 2−ΔCt × 105 indicating the difference in threshold cycle between the housekeeping gene GAPDH and the investigated TLR gene
Fig. 2 Toll-like Receptor (TLR) mRNA expression by primary nasal epi-
thelial cells from one representative patient. Expression of TLRs was 
analyzed by quantitative RT-PCR. Products were visualized by agarose 
gel-electrophoresis in a 2 % agarose gel
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but independently of these differences, also the response 
induced by a specific TLR ligand varies strongly between 
individuals. And finally, the mediator response varies 
between different TLRs, even when they are thought to 
act through a common pathway. This complex level of 
variation in TLR signaling suggests that different healthy 
individuals may see different environments despite iden-
tical exposure. Although it should be noted that our sam-
ple size of 10 healthy individuals is relatively small, so 
that it would be difficult to generalize our conclusions for 
the general population
The expression of TLRs within the lower respira-
tory tract has been investigated intensively [22, 24, 25, 
35], while data on TLR expression and functionality in 
nasal epithelial cells from healthy individuals is limited. 
Our experiments showed that primary nasal epithe-
lial cells from most healthy donors express mRNA for 
TLR 1–6 and TLR9 and mainly respond to the TLR3 
ligand Poly(I:C) and to the TLR2 and TLR5 agonists. The 
expression of TLR2, 3, and 4 has been shown in nasal 
epithelial cells derived from nasal polyps, with poly(I:C) 
inducing the secretion of RANTES, IP-10, IL-8 and GM-
CSF [29]. We were able to confirm this outcome and in 
addition show a consistent and statistically significant 
up-regulation of IL-2R, VEGF, MIP-1β in all individuals. 
Closer inspection of our data shows strong up-regulation 
of other mediators as well (e.g. Mip-1α, MCP1, IL-7). 
However, as the induced expression of these mediators 
varies so strongly between individuals this up-regulation 
does not reach statistical significance. These observa-
tions show that healthy individuals differ strongly in their 
Fig. 3 Primary nasal epithelial cells of non-allergic individuals were stimulated for 24 h with different TLR ligands. IL-6 and IL-8 production was 
measured after 24 h by ELISA. Results from one representative patient are shown as fold induction compared to unstimulated cells
Fig. 4 NCI-H292 cells were stimulated for 24 h with LPS (1 μg/ml) 
and TNF-α (25 ng/ml) and IL-1β (10 ng/ml). Cell free supernatants 
were analyzed for the release of IL-6 and IL-8 by ELISA
Fig. 5 MD-2 and CD14 mRNA expression by primary nasal epithelial 
cells from healthy patients (n = 9) and NCI-H292 cells. MD-2 and 
CD14 mRNA expression was analyzed by quantitative RT-PCR. Results 
were normalized using GAPDH as endogenous control. Expression 
changes are presented as 2−ΔCt × 105 indicating the difference in 
threshold cycle between the housekeeping gene GAPDH and the 
investigated genes
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response to external triggers, which will contribute to dif-
ferences between the ability to fight off viral and bacte-
rial infections. The absence of TLR7 and TLR10 mRNA 
expression differs from the previous observations of Ren-
konen [36] and Tengroth [30]. In both previous reports 
expression levels at the mRNA were low, so that differ-
ences in our detection technique (real time PCR) versus 
microarray [36] or differences in growth conditions [30, 
36] may help to explain the observed expression differ-
ences for TLR7 and TLR10. Allowing for the specificity of 
TLR antibodies both TLR7 and TLR10 could be detected 
by immuno-histochemistry with moderate biological 
activity for the TLR7 agonist relative to TLR3 activation 
[30, 36].
The most striking discrepancy between TLR expres-
sion and responsiveness we observed for TLR4. Despite 
the presence of the receptor on the cell surface, the pres-
ence of key co-stimulatory molecules (CD14 and MD-2) 
and a seemingly intact downstream signaling cascade 
(the cells do response to other TLR stimulations), nasal 
epithelial cells do not respond to LPS. This unresponsive-
ness has also been observed in the epithelia of the gut 
where it was attributed to missing MD-2 expression [37] 
and in nasal epithelium from polyposis patients by Wang 
and co-workers [29]. Nasal polyposis epithelium showed 
a much weaker response to LPS than to polyIC stimula-
tion, indicating that even in diseased tissue the nasal 
epithelial response to LPS is affected. In contrast, lung 
or renal epithelia are able to respond to LPS which sug-
gests that the hypo-responsiveness could be an adapta-
tion in epithelia that are exposed to high concentrations 
of LPS, whereas epithelia that are relative sterile do show 
a response to LPS.
The functional consequences of responding to TLR 
ligation are many. Expression of IP-10, MIP-1α, MIP-1β, 
IL-8 and G-CSF after TLR3 activation contribute to the 
recruitment and activation of neutrophils or macrophages. 
Furthermore, IL-8 and RANTES have been shown to be 
involved in the recruitment and survival of eosinophils 
[38]. These findings imply a role for TLR3 in the nasal 
immune response not only in Th1-mediated responses, 
but also in viral induced allergic exacerbations. This notion 
would also be in line with our recent observation that 
many aspects of TLR3 activation of nasal epithelial cells 
resemble that of activation by house dust mite allergen 
[39]. The inflammatory features of dsRNA mediated by 
TLR3 are also thought to contribute to the exacerbation 
of CRS and nasal polyps during viral infection [40]. TLR4 
expression on lung epithelial cells has been shown to be 
required for DC activation in the lung and for priming of 
effector T helper response to HDM [16]. In the absence of 
TLR ligation, lung DCs are minimally active. Binding with 
the TLR4 ligand LPS leads to enhanced motility and sam-
pling behavior. This response strictly depends on neigh-
boring epithelial cells being triggered by TLR4. In addition, 
responses to allergens are substantially altered when epi-
thelial cells cannot detect the endotoxin in the allergen, 
Fig. 6 Expression of TLR4 and CD14. Surface expression of TLR4 
and CD14 on primary nasal epithelial cells was assessed using flow 
cytometry. Histograms with solid lines represent controls, spotted 
lines display surface expression of TLR4 (upper graph) or CD14 (lower 
graph) under unstimulated conditions. Histograms with dashed lines 
illustrate TLR4 (upper graph) or CD14 (lower graph) expression upon 
stimulation with LPS (1 μg/mL, 24 h)
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indicating that TLR4 signaling in epithelial cells is critical 
for the initiation of Th2 responses to inhaled allergens [41].
Conclusions
Expression of TLRs on structural cells like epithelial 
cells and the respective functionality in terms of released 
mediators are important factors in the orchestration of 
local immune responses. We investigate the expression 
of all TLR receptors in primary nasal epithelial cells of 
healthy individuals and show an absence of TLR7 and 
TLR8 together with huge individual differences in mRNA 
expression level for TLR1-6 and TLR9. Although mRNA 
expression of TLRs of often taken as a measure of their 
activity we show that this is should be done with caution. 
Specific TLR agonist-induced mediator release in nasal 
epithelial cells is very variable between different indi-
viduals and does not correlate with the expression levels 
of the respective TLRs, although we show this only for 
a relative small number of individuals. Most notably we 
show that despite the presence of TLR4, CD14, and MD2 
in nasal epithelial cells, stimulation with LPS does not 
induce any mediator response. Supporting and strength-
ening previous observations in nasal polyposis patients 
that nasal epithelial cells seem to resemble gut epithelial 
cells where a yet unidentified mechanism prevents epi-
thelia routinely exposed to bacterial flora from fortuitous 
Table 1 Primary nasal epithelial cells of  5 non-allergic individuals were stimulated for  24  h with  different TLR ligands: 
TLR2 (PGN: 10 μg/ml), TLR3 (Poly(I:C): 20 μg/ml), TLR4 (LPS 1 μg/ml)
Cell free supernatants were analysed using a Luminex array. Concentrations are presented as average of triplicates of 5 different patients in pg/ml. The detection limits 
are shown as cut off value
SD Standard deviation, BD below detection level
** P < 0.05
Cut off value IMDM Poly(I:C) LPS PGN
Mean SD Mean SD Mean SD Mean SD
IL-1β 20 BD 26 28 BD BD
IL1RA 15 198 151 713** 487 219 111 337** 179
IL-2 3 BD 13 15 BD BD
IL-4 3 BD 13** 12 BD BD
IL-5 2 BD BD BD BD
IL-6 3 351 331 1793** 1491 264 256 548** 521
IL-7 3 24 36 132 122 34 35 45 44
IL-10 16 BD BD BD BD
IL-12 8 BD 46 27 BD BD
IL-13 4 BD BD BD BD
IL-15 6 BD 28 27 BD BD
IL-17 7 17 19 26 32 11 17 10 20
Eotaxin 6 BD BD BD BD
FGF basic 15 BD 40** 40 BD BD
G-CSF 2 72 95 655** 700 BD 132 179
GMCSF 4 36 74 58 148 18 47 20 48
INF γ 80 BD BD 16 BD BD
IP-10 24 BD 1982** 1666 BD 29 27
MCP 1 6 219 111 414 456 204 107 278 216
MIP1α 2 8 16 1122 2376 4 10 4 11
MIP1β 38 BD 930** 1321 BD BD
MIG 4 5 11 23 22 BD BD
RANTES 5 19 23 2120** 1516 18 21 25 25
TNFα 10 BD 43 68 BD BD
VEGF 9 191 163 482** 508 161 142 262** 189
EGF 1 BD 5 10 BD 1 4
HGF 66 BD 31 28 BD BD
IL-2R 7 70 52 632** 491 65 36 99 63
IFNα 2 14 21 39 39 10 18 22 20
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activation. Our data suggest that we should probably 
consider individual expression and activation levels bet-
ter as this would affect how individuals see their micro-
bial environment.
Abbreviations
TLR: Toll-like receptors; PAMP: pathogen-associated molecular patterns; 
PRR: pattern recognition receptors; LPS: lipopolysaccharide; Poly(I:C): 
poly(deoxyinosinic-deoxycytidylic) acid; PGN: peptidoglycan; CpG: cytosine—
phosphate—guanine; TNF-α: tumor necrosis factor-alpha; IL: interleukin; 
RANTES: regulated upon activation, normal T cell Expressed, and Secreted; 
IP-10: interferon gamma-induced protein 10; MIP-1β: macrophage inflamma-
tory protein 1 beta; VEGF: vascular endothelial growth factor; FGF: fibroblast 
growth factor; G-CSF: granulocyte colony-stimulating factor; RAST: radioal-
lergosorbent test; DC: dendritic cells; RT-PCR: realtime PCR; HBSS: Hanks’ 
balanced salt solution; MACS: magnetic activated cell sorting.
Authors’ contributions
JT and SR provided the clinical samples; JT, KR, SR, and SL did the experiments. 
JT, KR, and CvD performed the analysis, interpreted the data and have written 
the first draft of the manuscript. JvT, WF, EJ, and CD designed the experi-
ments and helped interpreting the data. WF and EJ edited the manuscript. All 
authors read and approved the final manuscript.
Author details
1 Department of Otorhinolaryngology, Academic Medical Center (AMC), 
Amsterdam, The Netherlands. 2 Department of Cell Biology & Histology, Aca-
demic Medical Center (AMC), Amsterdam, The Netherlands. 
Acknowledgements
J van Tongeren received a ZonMw fellowship (92003459), furthermore this 
study was supported by the Interuniversity Attraction Poles programme 
(IUAP)—Belgian state—Belgian Science Policy P6/35.
Competing interests
The authors declare that they have no competing interests.
Received: 8 September 2015   Accepted: 24 November 2015
References
 1. Toppila-Salmi S, van Drunen CM, Fokkens WJ, Golebski K, Mattila P, 
Joenvaara S, Renkonen J, Renkonen R. Molecular mechanisms of nasal 
epithelium in rhinitis and rhinosinusitis. Curr Allergy Asthma Rep. 
2015;15(2):495.
 2. van Tongeren J, Reinartz SM, Fokkens WJ, de Jong EC, van Drunen 
CM. Interactions between epithelial cells and dendritic cells in airway 
immune responses: lessons from allergic airway disease. Allergy. 
2008;63(9):1124–35.
 3. Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect 
danger: aiding the immune response. Allergy. 2008;63(9):1110–23.
 4. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev 
Immunol. 2002;20:197–216.
 5. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking 
innate and acquired immunity. Nat Immunol. 2001;2(8):675–80.
 6. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin 
Immunol. 2006;117(5):979–87.
 7. Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, et al. 
Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand 
spectrum but does not lead to differential signaling. J Leukoc Biol. 
2008;83(3):692–701.
 8. Takeuchi O, Hoshino K, Akira S. Cutting edge: tLR2-deficient and MyD88-
deficient mice are highly susceptible to Staphylococcus aureus infection. J 
Immunol. 2000;165(10):5392–6.
 9. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. 
Pattern recognition receptors TLR4 and CD14 mediate response to 
respiratory syncytial virus. Nat Immunol. 2000;1(5):398–401.
 10. Wang JE, Warris A, Ellingsen EA, Jorgensen PF, Flo TH, Espevik T, 
et al. Involvement of CD14 and toll-like receptors in activation of 
human monocytes by Aspergillus fumigatus hyphae. Infect Immun. 
2001;69(4):2402–6.
 11. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, 
et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-
defensin 2. Science. 2002;298(5595):1025–9.
 12. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar 
M. Cutting edge: the immunostimulatory activity of the lung surfactant 
protein-A involves Toll-like receptor 4. J Immunol. 2002;168(12):5989–92.
 13. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. 
HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal 
pathway. J Biol Chem. 2002;277(17):15107–12.
 14. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like 
receptor recognizes bacterial DNA. Nature. 2000;408(6813):740–5.
Fig. 7 Cytokine and chemokine secretion by stimulated primary nasal epithelial cells. Primary nasal epithelial cells of 5 non-allergic individuals were 
stimulated for 24 h with the TLR3 agonist Poly(I:C). Cell free supernatants were analysed using a Luminex array. Concentrations are presented as 
average of triplicates of 5 different patients
Page 9 of 9van Tongeren et al. Clin Transl Allergy  (2015) 5:42 
 15. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small 
anti-viral compounds activate immune cells via the TLR7 MyD88-
dependent signaling pathway. Nat Immunol. 2002;3(2):196–200.
 16. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. 
House dust mite allergen induces asthma via Toll-like receptor 4 trigger-
ing of airway structural cells. Nat Med. 2009;15(4):410–6.
 17. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, Broide DH, 
et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 
immune response and promotes experimental asthma. J Immunol. 
2004;172(5):2739–43.
 18. Hollingsworth JW, Whitehead GS, Lin KL, Nakano H, Gunn MD, Schwartz 
DA, et al. TLR4 signaling attenuates ongoing allergic inflammation. J 
Immunol. 2006;176(10):5856–62.
 19. Page K, Ledford JR, Zhou P, Wills-Karp M. A TLR2 agonist in German 
cockroach frass activates MMP-9 release and is protective against allergic 
inflammation in mice. J Immunol. 2009;183(5):3400–8.
 20. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bot-
tomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-depend-
ent T helper cell type 2 responses to inhaled antigen. J Exp Med. 
2002;196(12):1645–51.
 21. Jia HP, Kline JN, Penisten A, Apicella MA, Gioannini TL, Weiss J, et al. Endo-
toxin responsiveness of human airway epithelia is limited by low expres-
sion of MD-2. Am J Physiol Lung Cell Mol Physiol. 2004;287(2):L428–37.
 22. Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M. Differences in LPS-
induced activation of bronchial epithelial cells (BEAS-2B) and type II-like 
pneumocytes (A-549). Scand J Immunol. 2002;56(3):294–302.
 23. Thorley AJ, Grandolfo D, Lim E, Goldstraw P, Young A, Tetley TD. Innate 
immune responses to bacterial ligands in the peripheral human lung—
role of alveolar epithelial TLR expression and signalling. PLoS One. 
2011;6(7):e21827.
 24. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van HA, et al. Toll-like 
receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir 
Cell Mol Biol. 2004;30(6):777–83.
 25. Ritter M, Mennerich D, Weith A, Seither P. Characterization of Toll-like 
receptors in primary lung epithelial cells: strong impact of the TLR3 
ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins 
and inflammatory response. J Inflamm (Lond). 2005;29(2):16.
 26. Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells 
express functional Toll-like receptors, NOD1 and NOD2 to produce anti-
microbial peptides, but not proinflammatory cytokines. Mol Immunol. 
2007;44(12):3100–11.
 27. Claeys S, de BT, Holtappels G, Gevaert P, Verhasselt B, van CP, et al. Human 
beta-defensins and toll-like receptors in the upper airway. Allergy. 
2003;58(8):748–53.
 28. Lin CF, Tsai CH, Cheng CH, Chen YS, Tournier F, Yeh TH. Expression of 
Toll-like receptors in cultured nasal epithelial cells. Acta Otolaryngol. 
2007;127(4):395–402.
 29. Wang J, Matsukura S, Watanabe S, Adachi M, Suzaki H. Involvement of 
Toll-like receptors in the immune response of nasal polyp epithelial cells. 
Clin Immunol. 2007;124(3):345–52.
 30. Tengroth L, Millrud CR, Kvarnhammar AM, Kumlien Georén S, Latif L, Card-
ell LO. Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 
stimulation in nasalepithelial cells. PLoS One. 2014;9(6):e98239.
 31. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, et al. Toll-like 
receptor heterodimer variants protect from childhood asthma. J Allergy 
Clin Immunol. 2008;122(1):86–92, 92.
 32. Lebre MC, van der Aar AM, van BL, Van Capel TM, Schuitemaker JH, 
Kapsenberg ML, et al. Human keratinocytes express functional Toll-like 
receptor 3, 4, 5, and 9. J Invest Dermatol. 2007;127(2):331–41.
 33. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, 
et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of 
LPS to CD14. J Exp Med. 1994;179(1):269–77.
 34. Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, Dileepan KN, et al. A 
complex of soluble MD-2 and lipopolysaccharide serves as an activating 
ligand for Toll-like receptor 4. J Biol Chem. 2004;279(33):34698–704.
 35. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway 
epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol. 
2004;31(3):358–64.
 36. Renkonen J, Toppila-Salmi S, Joenväärä S, Mattila P, Parviainen V, 
Hagström J, et al. Expression of Toll-like receptors in nasal epithelium in 
allergic rhinitis. APMIS. 2015;123(8):716–25.
 37. Lenoir C, Sapin C, Broquet AH, Jouniaux AM, Bardin S, Gasnereau I, et al. 
MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in 
human intestinal epithelial cells. Life Sci. 2008;82(9–10):519–28.
 38. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated 
accumulation of eosinophils in inflammatory disease. Allergy. 
2004;59(8):793–805.
 39. Golebski K, Luiten S, van Egmond D, de Groot E, Röschmann KI, Fokkens 
WJ, van Drunen CM. High degree of overlap between responses to a virus 
and to the house dust mite allergen in airway epithelial cells. PLoS One. 
2014;9(2):e87768.
 40. Fransson M, Adner M, Erjefalt J, Jansson L, Uddman R, Cardell LO. Up-
regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Respir Res. 
2005;6:100.
 41. Tan AM, Chen HC, Pochard P, Eisenbarth SC, Herrick CA, Bottomly HK. 
TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 
responses to inhaled antigen. J Immunol. 2010;184(7):3535–44.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
